Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Aditx Therapeutics Inc (ADTX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Aditx's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
2.5300 +0.1600    +6.75%
16:00:04 - Closed. Currency in USD ( Disclaimer )
After Hours
2.5900
+0.0600
+2.3715%
18:47:40 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 174,983
  • Bid/Ask: 2.3500 / 2.6000
  • Day's Range: 2.2679 - 2.6900
Aditx 2.5300 +0.1600 +6.75%

Aditx Therapeutics Inc Company Profile

 
Get an in-depth profile of Aditx Therapeutics Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

61

Equity Type

Warrant

Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its own tissues. It is also developing ADi products for organ transplantation, including skin grafting, autoimmune diseases, and allergies. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia.

Contact Information

Address 737 North Fifth Street Suite 200
Richmond, 23219
United States
Phone 650 870 1200
Fax -

Top Executives

Name Age Since Title
Shahrokh Shabahang 60 2017 Co-Founder, Chief Innovation Officer, Secretary & Director
Brian Michael Brady 43 2018 Independent Director
Amro A. Albanna 53 2017 Co-Founder, Chairman & CEO
Jeffrey W. Runge 67 2020 Independent Director
Charles Athle Nelson 69 2023 Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ADTX Comments

Write your thoughts about Aditx Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
David Bari
David Bari Dec 08, 2023 6:14PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
you mean 1.60?
Anton Førby
Anton Førby Sep 07, 2023 4:16AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Pricetarget 160$
matanel liberman
matanel liberman Sep 06, 2023 3:26PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
60 soon
aldo palomino
aldo palomino Aug 18, 2023 11:30AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I have a question: If the share increases from 0.39 cents in the morning to 19.97 dollars 2 hours laterthe increase is only 24.97% ? Wouldn't the increase be 5,000%? someone explain to me, thank you
Pragmatic Bull
Pragmatic Bull Aug 18, 2023 11:30AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
You probably have figured this out by now, but divide the 19.97 by 40 first to account for the 1-40 reverse split
Octav Mogos
Octav Mogos Aug 18, 2023 10:03AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
hi, what happened with this stock? after oppening has disapeafr from my list. gone, vanish
Octav Mogos
Octav Mogos Aug 18, 2023 10:03AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
anybody?
aldo palomino
aldo palomino Aug 18, 2023 8:58AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Anybody knows what is happening with this share? 4,335% pre market is a madness
Levent KARA
Levent KARA Jul 25, 2023 8:09AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
0,37 is comingggg
Hi Wi
Hi Wi May 05, 2023 7:59AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Aditxt Subsidiary Adimune Signs Clinical Trial Agreement with Top Research Institution to Study Stiff Person Syndrome
Levent KARA
Levent KARA Feb 24, 2023 7:08AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
0,80 lodinggg
Romulus Son of Mars
Romulus7 Sep 14, 2022 12:02PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Damn, missed out 🙁
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email